Climb Bio, Inc. Common Stock
XNAS:CLYM
1.72
$1.74 - 6,694.00
$1.69 - 65.00
$1.69
$1.74
$1.72
$1.73
3.21
1.05
189864
286708.3
62390839.72
Chart
TendieTensor AI Analysis
Company
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
Fundamentals
18
-2.290000
0.662573
100
BBG00ZNKL0K6
BBG00ZNKL0L5
67.76M
67.76M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own CLYM. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.